申请人:Zhang Jing
公开号:US20100316649A1
公开(公告)日:2010-12-16
This disclosure concerns compounds which are useful as inhibitors of spleen tyrosine kinase (Syk) and are thus useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of Syk. This disclosure also relates to pharmaceutical compositions containing these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.
本公开涉及一些化合物,这些化合物可用作脾酪氨酸激酶(Syk)的抑制剂,因此对于治疗通过Syk的活动介导或维持的各种疾病和障碍非常有用。本公开还涉及含有这些化合物的药物组合物,使用这些化合物治疗各种疾病和障碍的方法,制备这些化合物的过程以及在这些过程中有用的中间体。